Search
Concerned about a growing number of fake and counterfeit drugs entering America, the Pharmaceutical Research and Manufacturers of America (PhRMA), along with several patient and advocacy groups, today released key findings from a PhRMA-sponsored survey that reveals some common characteristics and behaviors of Americans who are importing medicines from foreign countries. 25 June 2007 Read the full story at medadnews.com.
Read MoreChina’s resolve to clean up corruption in its pharma industry has intensified as the former assistant to the already-condemned-to-death former drug chief has now been charged. Cao Wenzhuan has become the third former State Food and Drug Administration (SFDA) official to be charged since this corruption scandal first broke last year. By Kirsty Barnes 25 June 2007 Read the…
Read MoreThe impact of the global multi-billion dollar trade on counterfeit drugs and its effects on the health sector and the quality of health care being afforded Guyanese cannot be accurately determined since the available mechanisms for monitoring the importation of drugs into Guyana are both inadequate and unreliable, according to Director of the Food and Drugs Department Marilyn Collins. Speaking…
Read MoreIn this issue of The Annals, Veronin et al.1 discuss drug quality with a comparison of simvastatin tablets from the US and Canada obtained via the Internet. Using near-infrared spectroscopic imaging, the research found that generic simvastatin manufactured in Canada was comparable to the brand-name product made in the US. The objective was to determine the risks to Americans who…
Read More